At the University of Virginia, scientists have created a groundbreaking treatment utilizing targeted ultrasound, microbubbles, and nanoparticles to transport microRNAs through the blood-brain barrier, focusing on several genes implicated in glioblastoma. This form of brain cancer is the most prevalent and aggressive malignant tumor in adults, leading to over 13,000 fatalities each year in the U.S. Preclinical trials in animals demonstrated reduced tumor progression and enhanced survival rates. These results may pave the way for upcoming clinical trials and contribute to the development of novel therapies for brain cancer and other neurological disorders.
